MELINDA RODGERS: Open Payments
NPI 1497765945 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 10 payments from 6 companies in 2025. Trend: 2023 $460 · 2024 $265 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $192 |
| Kite Pharma, Inc. | 2 | $39 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $18 |
| Alexion Pharmaceuticals, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: Niktimvo, JAKAFI, Yescarta, REZUROCK, Cresemba, ULTOMIRIS, PREVYMIS.
Industry payments across AL — which companies pay providers there.
